Article
Retinoblastoma genetics screening and clinical management
22 Jul 2021
Abstract excerpt
BACKGROUND: India accounts for 20% of the global retinoblastoma (RB) burden. However, the existing data on RB1 gene germline mutations and its influence on clinical decisions is minimally explored. METHODS: Fifty children with RB underwent complete clinical examination and appropriate multidisciplinary management. Screening of germline RB1 gene mutations was performed through next-generation sequencing and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
